Healthcare, Pharma & Life Sciences

Berlin – November 03, 2026 -- Net costs for outpatient drug care in Germany's statutory health insurance reached a record €62.6 billion, according to an analysis by the AOK's Scientific Institute (WIdO) on the 2027 pharmaceutical market. Dr. Carola Reimann, chair of the AOK Federal Association, warned that a planned location clause could erase the savings the current cost-containment package delivers.

WIdO projects 2027 drug cost growth of 2.2% to 2.8%

The institute attributes the moderate outlook to the higher manufacturer rebate for 2027. It expects drug costs to rise by 2.2% to a maximum of 2.8%. WIdO experts caution that the relief is short-lived and call for structural reform, above all of the AMNOG procedure, which governs the pricing of new drugs.

Dijon – November 03, 2026 -- PROTEOR is introducing two lower-limb prosthetic feet worldwide: EXONEO CORE, built specifically for K2 ambulators, and HOPPER OUTSIDER, a foot designed to cover both everyday walking and dynamic activity.

EXONEO CORE targets the stability-versus-comfort trade-off for K2 users

EXONEO CORE is a biomimetic foot developed for community ambulators classified as K2. PROTEOR says a foot built for comfort can feel less stable, while a stable design can feel rigid. The company describes EXONEO CORE as purpose-built for K2 mobility rather than an adapted higher-activity foot.

Plantar springs absorb vertical loads and adapt to uneven terrain, and the foot keeps ground contact through toe-off. Natural toe extension of up to 20 degrees supports stability in the final phase of each step. The low-profile construction adds fitting versatility for clinicians.

Bronx, N.Y. – – November 03, 2026 -- The National Cancer Institute (NCI) has awarded a five-year, $10 million grant to a multi-institutional team led by Julio A. Aguirre-Ghiso, Ph.D., of Montefiore Einstein Comprehensive Cancer Center (MECCC). The money will fund research into the biological processes behind breast cancer relapse and into ways to predict and prevent recurrence.

The NCI estimates that up to 685,000 people die from breast cancer worldwide each year. Nearly all fatal cases involve disease that returns in other organs years or decades after surgery, chemotherapy or radiation.

Brookfield, Conn. – November 03, 2026 -- Medicare's CJR-X model will place 2,217 hospitals under mandatory two-sided financial risk on January 1, 2028. CMS's final rule projects those hospitals will repay $1.855 billion over five years while receiving $1.463 billion.

The model makes hospitals responsible for the full cost of hip, knee and ankle replacements through 90 days after discharge. Hospitals that beat a regional target price earn a bonus, while those that miss it pay Medicare back.

CMS projects a net $392 million transfer from hospitals to Medicare

The repayment gap leaves a net $392 million flowing to Medicare. More than half of the projected $736 million in savings comes from pricing alone.

Predecessor CJR left 60% of participating hospitals owing money in 2023

The earlier CJR program shows the direction of travel:

SUNNYVALE – – November 03, 2026 -- Cepheid, a Danaher operating company, has received U.S. Food and Drug Administration clearance for the Xpert Hemorrhagic Fever Panel, a multiplex PCR test that detects four hemorrhagic fever virus groups from a single sample in approximately 61 minutes.

Single cartridge covers Ebola, Marburg, Lassa and CCHF

The panel gives qualitative detection and identification of RNA from Ebola virus, Marburg virus, Lassa virus and Crimean-Congo hemorrhagic fever (CCHF) virus. The Ebola target covers the Zaire, Sudan, Taï Forest and Bundibugyo species, which the test does not differentiate.

The test runs on Cepheid's GeneXpert Dx systems. Its closed-cartridge design limits cross-contamination between samples, and sample processing includes viral inactivation to support safe laboratory workflows.

Hannover – November 03, 2026 -- Care providers in Lower Saxony answer to 54 separate inspection and oversight bodies, and about 5,000 jobs in the state are at risk if a federal reform takes effect on schedule, according to the private providers' association bpa.

State chair Ricarda Hasch presented the figures at the association's general assembly in Hannover, attended by around 200 representatives of care facilities from across Lower Saxony. She said bpa is not asking to lower quality standards or scrap necessary inspections. Her complaint is that different authorities repeatedly check the same matters and demand documentation that adds no visible value to care quality.

ATLANTA – November 03, 2026 -- Cerbo has extended its native AI Scribe to virtual visits at no additional cost for users of Cerbo Telemedicine or the Zoom integration, three months after the tool launched in the exam room.

AI Scribe now captures Telemedicine and Zoom visits and drafts the note inside the chart

The electronic health record (EHR) platform for cash-pay, personalized-care practices said AI Scribe listens to the conversation on virtual visits and drafts a structured note in the Cerbo chart. The provider reviews, edits and signs the note, and nothing commits to the patient record without that sign-off.

AI Scribe launched in August as a scribe built into the EHR, with no separate login, dictation app or copy-and-paste between systems. Virtual visit support is available to Cerbo customers now under Settings > AI Scribe.

Berlin – November 03, 2026 -- 84 percent of participants in the pilot phase of a new climate anxiety prevention program said it left them feeling strengthened, according to initial unpublished results from health insurer mkk - meine krankenkasse.

Insurer targets student mental health with multi-stage program

mkk developed the multi-stage program with the Hamburg University of Applied Sciences (HAW Hamburg) and students. Its aims are to support young people in coping with climate anxiety, strengthen their mental health and open up new courses of action.

The program responds to survey findings that more than half of students in Germany report strong to extremely strong fear of climate change and related psychological strain.

Filderstadt – November 03, 2026 -- DRF Luftrettung, one of Europe's largest air rescue organizations, took first place at the Award Patientendialog 2026, its third quality and patient-safety distinction in three years. An independent jury honored its project "Communication and Patient Safety in Air Rescue." The result was announced on 23 October at the BPiK symposium in Haar near Munich.

The award is granted by the Federal Association of Patient Advocates in Hospitals (BPiK e. V.) and the Federal Association of Complaint Management for Healthcare Institutions (BBfG e. V.). It recognizes organizations that foster dialogue with patients and relatives and involve them in care.

Laval – November 03, 2026 -- Spektus Pharma and GEBRO Holding have agreed a global commercialization partnership for ActraFlex, a twice-daily extended-release tramadol/paracetamol formulation for pain management.

GEBRO takes Europe and Spektus takes the Americas under a split-territory deal

GEBRO, headquartered in Fieberbrunn, Austria, will lead commercialization and supply across Europe and selected international markets. The rollout is anchored by Spain, where GEBRO's Diliban brand has an established commercial presence.

Spektus, a Canadian specialty pharmaceutical company, will lead commercialization and supply across the Americas and selected markets in Africa and Asia. It will work through its network of regional pharmaceutical partners.

Each company will lead regulatory approvals in its own territories.